Mustapha Issa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In the last decade a number of new device technologies have appeared for benign prostatic hyperplasia (BPH) therapy. These technologies have been introduced in an effort to reduce the morbidity of BPH therapy occasioned by conventional electrocautery transurethral resection of the prostate (TURP). Whilst morbidity is reduced, the aim of new therapy is to(More)
  • 1